Feature Channels:

Men's Health

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Prostate Cancer, Radiation Therapy, quality of life in cancer , hypofractionated radiation therapy

Study: Shortened Radiation Therapy Offers Similar Quality of Life for Low-Risk Prostate Cancer Patients

Movsas_Benjamin_13C.jpg

Low-risk prostate cancer patients may be able to undergo a shortened course of radiation therapy that cuts treatment by weeks and offers comparable outcomes and quality of life results as those who undergo longer treatment courses.

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Prostate Cancer, intermediate risk prostate cancer, Brachytherapy, External Beam Therapy, EBT

Intermediate Risk Prostate Cancer May Be Well Controlled with Brachytherapy Alone

PrestidgeHeadshot.jpg

For men with intermediate risk prostate cancer, radiation treatment with brachytherapy alone can result in similar cancer control with fewer long-term side effects, when compared to more aggressive treatment that combines brachytherapy with external beam therapy (EBT), according to research presented today at the 58th Annual Meeting the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, hypofractionated radiation therapy, low-risk prostate cancer, Prostate Cancer, NRG Oncology/RTOG 0415

Hypofractionated RT Can Reduce Treatment Time by One-Third with Comparable QOL for Prostate Cancer Patients

BrunerHeadshot.jpg

For men with early stage, low-risk prostate cancer, treatment with hypofractionated radiation therapy (RT) offers comparable health-related quality of life outcomes in one-third less treatment time than conventional RT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Life

Law and Public Policy

Channels:

Health Disparities, black gay men, Black men

Black Men and Health Disparities 

What is the role of law and policy in eliminating racial health disparities? That is one of many topics to be discussed at “Black Men and Health Disparities,” an O’Neill Institute for National and Global Health Law Colloquium on Wednesday, Sept. 28.

Medicine

Channels:

Prostate Cancer, Radical Prostatectomy, imrt, Astro Annual Meeting, Astro, New Jersey, Rutgers University

Radiation Therapy and Radical Prostatectomy Further Explored for Initial Diagnosis of Advanced Prostate Cancer

parikh_12suit2015DVogel.jpg

A database study examining surgical removal of the prostate gland (radical prostatectomy) or a form of radiation therapy known as IMRT to treat prostate cancer that has spread to other parts of the body (metastatic) shows an association between each of these treatments and improved overall survival.

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Prostate Cancer, extremely-hypofractionated treatment, , HYPO-RT-PC trial

Extremely Hypofractionated Radiation Therapy Shows Promising Toxicity Results for Intermediate Risk Prostate Cancer Patients

WidmarkHeadshot.jpg

For men with intermediate risk prostate cancer, side effects at two years following radiation therapy (RT) were comparable for extremely-hypofractionated treatment, which was delivered in seven fractions across two and a half weeks, and conventional treatment of 39 fractions across eight weeks, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Channels:

Astro, Astro Annual Meeting, American Society For Radiation Oncology, Radiation Therapy, Radiation Oncology, Cancer Research, Prostate Cancer, molecular subtypes

Three Novel Intrinsic Subtypes of Prostate Cancer Identified

SprattHeadshot.jpg

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to treatment, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Medicine

Science

Channels:

Homicide, Alcohol, alcohol-involved homicide, male gender, Domestic Abuse, minority status, Alcohol Policies, Victims

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Sep-2016 5:00 PM EDT

Medicine

Channels:

Testosterone, clinical trial, Cardiovascular Health, Sexual Function, Physical Function, Testosterone Supplements

Study Questions Benefits of Testosterone Replacement for Low T

The prescription of testosterone supplementation for cardiovascular health, sexual function, physical function, mood, or cognitive function in men with “low T” is not supported by clinical trials data, conclude researchers who describe a review of more than 200 clinical trials published Sept. 21 in PLOS One.

Medicine

Channels:

Prostate Cancer, liquid biopsy, cancer biopsy, Circulating Tumor Cells

Duke Team Identifies Blood Biomarkers in Drug-Resistant Cancer Tumor Cells

Prostate.01.crop.jpg

While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies.

Medicine

Science

Life

Business

Law and Public Policy

Channels:

Presidential Debate: Expert Panel Gives Scientific Analysis of Candidates' Performances

Four expert panelists each day will present their analyses and answer your questions live and face-to-face. This event will be virtual. You can attend with any device -- PC, Mac, iPad, iPhone or Android device (with a webcam) – anywhere with good bandwidth. To participate (ask questions) in the meeting, you must be on video, just as a normal news conference. Register below for guaranteed seating; there is limited seating in the virtual room. Eight experts (four at each event) will present their analyses. The diverse expert team (7 universities and an institute) will analyze both candidates during the debates for their gestures, facial expressions (including smiles--number, type, appropriateness, etc.), posture, language, including sentiment, tone, inflammatory language, repetition, vocabulary, sentence structure, metaphors, framing, themes, suggestions, subtlety, nuance, honesty (deceit/lies—explicit and implicit), transparency, gender issues, and more...

Medicine

Channels:

Jennifer Elisseeff, Elisseeff, William Romani, Romani, ACL, Testosterone

New Evidence That Testosterone May Explain Sex Difference in Knee Injury Rates

TornLigamentACLSMALL.jpg

In studies on rats, Johns Hopkins Medicine scientists report new evidence that the predominance of the hormone testosterone in males may explain why women are up to 10 times more likely than men to injure the anterior cruciate ligament (ACL) in their knees.

Medicine

Channels:

Astro, Protect, Prostate Cancer, Radiation Therapy

ASTRO Encourages Prostate Cancer Patients to Weigh Long-Term Impact of Treatment Options with Their Doctors

In light of the findings from the Prostate Testing for Cancer and Treatment (ProtecT) trial published today in the New England Journal of Medicine, the American Society for Radiation Oncology (ASTRO) would like to congratulate the authors and investigators for conceiving and completing a difficult clinical trial to randomize care for 2,664 men who volunteered to be a part of this study.

Medicine

Channels:

Cancer, Fat, Sugar, AML, Prostate Cancer

Taste for Fat

AchillesHeel-MHagis_120.jpg.jpeg

Most cancers have a sweet tooth but—mysteriously—some tumors prefer fat over sugar. Now, a study from Harvard Medical School reveals how these cancers develop their appetite for fat.

Science

Channels:

AMP Study Explores Potency of Antibodies to Combat HIV Infection

ampstudy1lores.jpg

A clinical trial underway – known as the AMP study (for Antibody Meditated Prevention) – will determine whether infusing an experimental antibody (VRC01) into HIV-negative men and transgender individuals who have sex with men, will prevent the acquisition of HIV.

Medicine

Channels:

American Society of Nephrology’s Kidney Week 2016: Reinventing Nephrology: From Molecule to Man

The world’s largest gathering of kidney health professionals will join forces in Chicago from November 15–20, 2016, to discuss research discoveries and how to move them from bench to bedside during the American Society of Nephrology’s Kidney Week 2016.

Medicine

Channels:

Fusion Biopsy, Prostate Cancer, 3D imaging, 3D model, 3D image, Cancer, Ut Southwestern

Fusion Targeted Prostate Biopsy Proves More Accurate in Diagnosis of Prostate Cancer

costa-pedrosa-imaging-body.png

New research confirms that an innovative procedure combining MRI and ultrasound to create a 3D image of the prostate can more accurately locate suspicious areas and help diagnose whether it’s prostate cancer.

Life

Social and Behavioral Sciences

Channels:

Men's Hidden Body Fat Fears Fueling Gym Attendance

Men's hidden fears about body fat are fuelling gym attendance motivated by feelings of guilt and shame rather than a desire to build muscle, new research has shown.

Medicine

Channels:

Prostate Cancer, Precision Medicine, personalized medicine, gene activation, Targeted Therapy, Michael Freeman PhD

New Tumor Analysis Method Identifies High-Risk Prostate Cancer

Scientists at Cedars-Sinai have developed a new way to identify which prostate cancer patients are likely to develop aggressive types of the disease even if their tumors at first appear to be lower risk. The new findings could help physicians prescribe the most effective treatments for each patient based on how genes are activated in the individual tumor.

Medicine

Channels:

Prostate Cancer, metastatic prostate cancer, Pet Scan, fluciclovine F-18, fluorine-18

New PET Scan for Prostate Cancer Patients

Loyola Medicine is the first center in the Midwest to offer the first effective PET/CT scan for prostate cancer patients. The scan can detect the location and extent of cancer that has recurred after initial treatment. Prostate PET/CT scans can detect cancer earlier than either CT scans alone or MRI scans.







Chat now!